HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aesthetic Medicine

661.020

+1.3930.21%

Number of Gainers:5

Number of Losers:4

Number of Flat:4

PE:- -

High:664.904

Open:659.627

Low:650.900

Close:659.627

Loading ...

3SBio's Lung Cancer Drug Gets Breakthrough Therapy Designation in China

MT Newswires Live

BRIEF-3Sbio Says 707 Injection (Anti-Vegf/Pd-1 Bispecific Antibody) Granted Breakthrough Therapy Designation By NMPA

3SBio - 707 Injection (Anti-Vegf/Pd-1 Bispecific Antibody) Granted Breakthrough Therapy Designation by Nmpa

THOMSON REUTERS

BRIEF-Sihuan Pharma Repurchased 10 Mln Shares At Average Price Of HK$0.6274 Per Share

Sihuan Pharma - Repurchased 10 Mln Shares at Average Price of HK$0.6274 per Share

THOMSON REUTERS

Shanghai Fosun Pharmaceutical to Sell 55% Stake in Investment Firm

MT Newswires Live

Corrected-Lai Fung Holdings H1 Turnover HKD 647.8 Million (Corrects Number)

THOMSON REUTERS

Angelalign Technology Inc. (HKG:6699) May Have Run Too Fast Too Soon With Recent 27% Price Plummet

Simply Wall St.

Sihuan Pharmaceutical Buys Back Shares

MT Newswires Live

BRIEF-Sihuan Pharma Intends To Exercise Its Powers Under General Mandate To Repurchase Shares Of Co

Sihuan Pharma - Intends to Exercise Its Powers Under General Mandate to Repurchase Shares of Company

THOMSON REUTERS

Sihuan Pharma - Repurchased 10 Mln Shares of Co at Average Price of HK$0.5866 per Share

THOMSON REUTERS

Fosun Pharmaceutical Unit Gets China Nod for Schizophrenia Drug Trial

MT Newswires Live

BRIEF-Sihuan Pharma Repurchased A Total Of 15 Million Shares Of Co

Sihuan Pharma - Repurchased a Total of 15 Mln Shares of Co at an Average Price of HK$0.5836 per Share

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK1593/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1593","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"Aesthetic Medicine","latestPrice":661.01984,"timestamp":1744877287900,"preClose":659.627,"halted":0,"volume":55838965,"delay":0,"changeRate":0.002112,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":1.392822,"latestTime":"04-17 16:00:00","open":659.627,"high":664.9042,"low":650.9004,"amount":454316717,"amplitude":0.02123,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745285400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1744853400000,1744862400000],[1744866000000,1744876800000]],"pbRate":1.198465,"peRate":18.442629,"turnoverRate":0.002669,"increases":5,"decrements":4,"flats":4,"marketCap":113879274736,"floatMarketCap":79517598000},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":664.9042,"amplitude":0.02123,"preClose":659.627,"low":650.9004,"pbRate":"1.198465","latestPrice":661.01984,"volume":55838965,"delay":0,"open":659.627,"prevYearClose":571.87146,"prevWeekClose":661.02,"prevMonthClose":677.607,"prevQuarterClose":677.607,"fiveDayClose":651.826,"twentyDayClose":681.88,"sixtyDayClose":540.682,"secType":"PLATE","market":"HK","turnoverRate":0.002669,"peRate":18.442629,"marketCap":113879274736,"floatMarketCap":79517598000,"timestamp":1744877287900,"nameCN":"Aesthetic Medicine"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":5,"down":4,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2528508155","title":"3SBio's Lung Cancer Drug Gets Breakthrough Therapy Designation in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2528508155","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528508155?lang=en_us&edition=fundamental","pubTime":"2025-04-18 12:19","pubTimestamp":1744949994,"startTime":"0","endTime":"0","summary":"3SBio  said its 707 injection was granted a breakthrough therapy designation by China's National Medical Products Administration, according to a late Thursday bourse filing.This designation provides benefits for 707's development as a first-line treatment for PD-L1-positive locally advanced or metastatic non-small cell lung cancer, the filing stated.Drugs with that designation are entitled to policy support, prioritized communication resources, enhanced guidance, and accelerated development.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","01530","BK1593","BK1583"],"gpt_icon":0},{"id":"2528919794","title":"BRIEF-3Sbio Says 707 Injection (Anti-Vegf/Pd-1 Bispecific Antibody) Granted Breakthrough Therapy Designation By NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2528919794","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528919794?lang=en_us&edition=fundamental","pubTime":"2025-04-17 18:29","pubTimestamp":1744885740,"startTime":"0","endTime":"0","summary":"BRIEF-3Sbio Says 707 Injection  Granted Breakthrough Therapy Designation By NMPAApril 17  - 3SBio Inc 1530.HK:707 INJECTION  GRANTED BREAKTHROUGH THERAPY DESIGNATION BY NMPAFurther company coverage: 1530.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nFWN3QU2L4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","01530","BK1593","BK1161"],"gpt_icon":0},{"id":"2528769933","title":"3SBio -  707 Injection (Anti-Vegf/Pd-1 Bispecific Antibody) Granted Breakthrough Therapy Designation by Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2528769933","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528769933?lang=en_us&edition=fundamental","pubTime":"2025-04-17 16:32","pubTimestamp":1744878747,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nFWN3QU2L4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1593","01530","BK1161","BK1583"],"gpt_icon":0},{"id":"2527288402","title":"BRIEF-Sihuan Pharma Repurchased 10 Mln Shares At Average Price Of HK$0.6274 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2527288402","media":"Reuters","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527288402?lang=en_us&edition=fundamental","pubTime":"2025-04-16 23:18","pubTimestamp":1744816681,"startTime":"0","endTime":"0","summary":"BRIEF-Sihuan Pharma Repurchased 10 Mln Shares At Average Price Of HK$0.6274 Per ShareApril 16 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd 0460.HK:REPURCHASED 10 MILLION SHARES AT AVERAGE PRICE OF HK$0.6274 PER SHAREFurther company coverage: 0460.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nFWN3QU110:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","BK1515","00460","BK1191","BK1593"],"gpt_icon":0},{"id":"2527962852","title":"Sihuan Pharma - Repurchased 10 Mln Shares at Average Price of HK$0.6274 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2527962852","media":"THOMSON REUTERS","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527962852?lang=en_us&edition=fundamental","pubTime":"2025-04-16 18:40","pubTimestamp":1744800030,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nFWN3QU110:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","BK1600","00460","BK1593","BK1191"],"gpt_icon":0},{"id":"2527137940","title":"Shanghai Fosun Pharmaceutical to Sell 55% Stake in Investment Firm","url":"https://stock-news.laohu8.com/highlight/detail?id=2527137940","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527137940?lang=en_us&edition=fundamental","pubTime":"2025-04-14 18:45","pubTimestamp":1744627530,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (Group) (HKG:2196, SHA:600196) agreed to sell a total equity stake of 55% in Shanghai Fujian Equity Investment Fund Management to three parties for around 26.5 million yu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0096","BK0187","BK0183","BK0012","02196","BK1515","BK0196","600196","BK0060","BK1593","BK0188","BK0239","BK0028","BK1191","00656","BK0175"],"gpt_icon":0},{"id":"2527131746","title":"Corrected-Lai Fung Holdings H1 Turnover HKD 647.8 Million (Corrects Number)","url":"https://stock-news.laohu8.com/highlight/detail?id=2527131746","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527131746?lang=en_us&edition=fundamental","pubTime":"2025-04-14 18:27","pubTimestamp":1744626470,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nL8N3QS0K2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01125","BK1593","BK1240"],"gpt_icon":0},{"id":"2527923216","title":"Angelalign Technology Inc. (HKG:6699) May Have Run Too Fast Too Soon With Recent 27% Price Plummet","url":"https://stock-news.laohu8.com/highlight/detail?id=2527923216","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527923216?lang=en_us&edition=fundamental","pubTime":"2025-04-14 09:29","pubTimestamp":1744594171,"startTime":"0","endTime":"0","summary":"Angelalign Technology Inc. ( HKG:6699 ) shareholders won't be pleased to see that the share price has had a very rough...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-6699/angelalign-technology-shares/news/angelalign-technology-inc-hkg6699-may-have-run-too-fast-too","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1587","FAST","BK1583","IE00BYQQ9H92.USD","BK1100","06699","BK4585","BK4588","IE00BFXG0V08.USD","BK1593","BK4104","IE00B5TLWC47.USD","BK4567"],"gpt_icon":0},{"id":"2526530555","title":"Sihuan Pharmaceutical Buys Back Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2526530555","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526530555?lang=en_us&edition=fundamental","pubTime":"2025-04-10 17:47","pubTimestamp":1744278472,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical  bought back 10 million shares from the market for nearly HK$5.9 million, or an average of HK$0.5866 apiece, a Wednesday filing with the Hong Kong bourse said.The shares represent roughly 0.1077% of the pharmaceutical company's issued share capital.The firm intends to hold the shares as treasury shares.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1515","BK1593","00460","BK1600","BK1191"],"gpt_icon":0},{"id":"2526991083","title":"BRIEF-Sihuan Pharma Intends To Exercise Its Powers Under General Mandate To Repurchase Shares Of Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2526991083","media":"Reuters","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526991083?lang=en_us&edition=fundamental","pubTime":"2025-04-09 23:25","pubTimestamp":1744212335,"startTime":"0","endTime":"0","summary":"BRIEF-Sihuan Pharma Intends To Exercise Its Powers Under General Mandate To Repurchase Shares Of CoApril 9  - Sihuan Pharmaceutical Holdings Group Ltd 0460.HK:INTENDS TO EXERCISE ITS POWERS UNDER GENERAL MANDATE TO REPURCHASE SHARES OF COMPANYREPURCHASED 10 MILLION SHARES OF CO AT AVERAGE PRICE OF HK$0.5866 PER SHAREFurther company coverage: 0460.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250409:nFWN3QM2AY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1191","BK1600","00460","BK1593"],"gpt_icon":0},{"id":"2526735796","title":"Sihuan Pharma - Intends to Exercise Its Powers Under General Mandate to Repurchase Shares of Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2526735796","media":"THOMSON REUTERS","labels":["buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526735796?lang=en_us&edition=fundamental","pubTime":"2025-04-09 19:25","pubTimestamp":1744197901,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250409:nFWN3QM2AY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["00460","BK1515","BK1600","BK1593","BK1191"],"gpt_icon":0},{"id":"2526335799","title":"Sihuan Pharma - Repurchased 10 Mln Shares of Co at Average Price of HK$0.5866 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2526335799","media":"THOMSON REUTERS","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526335799?lang=en_us&edition=fundamental","pubTime":"2025-04-09 19:25","pubTimestamp":1744197901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250409:nFWN3QM2AY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","BK1191","BK1600","00460","BK1593"],"gpt_icon":0},{"id":"2525830535","title":"Fosun Pharmaceutical Unit Gets China Nod for Schizophrenia Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2525830535","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525830535?lang=en_us&edition=fundamental","pubTime":"2025-04-08 15:00","pubTimestamp":1744095612,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical   unit Fosun Pharma  received clinical trial approval for its CMC-2310 Oral Soluble Film from China's National Medical Products Administration.The clinical trial will test the drug for the treatment of schizophrenia in adults and pediatric patients aged 13 and above, a Monday filing with the Hong Kong bourse said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0188","BK1593","BK0239","BK0060","BK0012","BK1191","00656","BK0187","BK0028","BK1230","BK0183","BK0196","BK1515","BK0175","BK0096","02196","600196"],"gpt_icon":0},{"id":"2525902270","title":"BRIEF-Sihuan Pharma Repurchased A Total Of 15 Million Shares Of Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2525902270","media":"Reuters","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525902270?lang=en_us&edition=fundamental","pubTime":"2025-04-08 01:36","pubTimestamp":1744047412,"startTime":"0","endTime":"0","summary":"BRIEF-Sihuan Pharma Repurchased A Total Of 15 Million Shares Of CoApril 7 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd 0460.HK:REPURCHASED A TOTAL OF 15 MILLION SHARES OF CO AT AN AVERAGE PRICE OF HK$0.5836 PER SHAREFurther company coverage: 0460.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nFWN3QL04Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","BK1593","BK1191","BK1515","00460"],"gpt_icon":0},{"id":"2525141260","title":"Sihuan Pharma -  Repurchased a Total of 15 Mln Shares of Co at an Average Price of HK$0.5836 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2525141260","media":"THOMSON REUTERS","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525141260?lang=en_us&edition=fundamental","pubTime":"2025-04-07 19:37","pubTimestamp":1744025840,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nFWN3QL04Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1515","00460","BK1593","BK1600"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}]}}